Biothera Pharmaceuticals to Present Clinical Data from Phase 2 Triple Negative Breast Cancer Study at ASCO 2019 Annual Meeting

    NEXT STORY
    Aptose to Present New Preclinical Data for CG-806 at the 24th Congress of The European Hematology Association
    PREV STORY
    Innovation Pharmaceuticals Announces Non-Binding Term Sheet Signed with Global Pharmaceutical Company to Develop and Commercialize Brilacidin for the Treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global Disposable Gloves Market was Valued at USD 7.6 billion in 2019 and is Expected to Reach USD 11.8 billion by 2025, Observing a CAGR of 7.7% during 2020–2025: VynZ Research

    author_avatar
    NASDAQ Market News

    Corvus Pharmaceuticals Announces Updated Clinical Data from Phase 1/1b Study of CPI-444 and Biomarker Data for Potential Use in Patient Selection

    – Clinical Data from Renal Cell Carcinoma Cohorts Presentedin Oral Session at SITC 32nd ...

    author_avatar
    NASDAQ Market News

    Immunicum AB (publ) meddelar kommande presentationer och deltagande i konferenser under maj och juni

    Pressmeddelande 14 maj 2018 Immunicum AB (publ) meddelar kommande presentationer och deltagande i konferenser ...

    author_avatar
    NASDAQ Market News